首页> 美国卫生研究院文献>Clinical Cardiology >Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta‐Analysis of Randomized Trials Performed With Stents and Thienopyridines

【2h】

Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta‐Analysis of Randomized Trials Performed With Stents and Thienopyridines

机译：普通肝素加糖蛋白IIb / IIIa抑制剂在急性冠脉综合征血运重建过程中的功效和安全性：对使用支架和噻吩并吡啶类药物进行的随机试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Early studies of glycoprotein IIb/IIIa inhibitors (GPIs) demonstrated benefit during percutaneous coronary intervention for acute coronary syndromes (ACS). Since their introduction, the magnitude of benefit of GPIs has become unclear.

机译：背景：糖蛋白IIb / IIIa抑制剂（GPI）的早期研究表明，经皮冠状动脉介入治疗对急性冠脉综合征（ACS）有好处。自从引入GPI以来，其收益的大小尚不清楚。

著录项

期刊名称 Clinical Cardiology
作者
David E. Winchester; William D. Brearley; Xuerong Wen; Ki E. Park; Anthony A. Bavry;
展开▼
作者单位

展开▼
年(卷),期 2012(35),2
年度 2012
页码 93–100
总页数 8
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
专利

1. Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: A meta-analysis of randomized trials performed with stents and thienopyridines [J] . WinchesterD.E., BrearleyW.D., WenX., Clinical cardiology. . 2012,第2期

机译：普通肝素加糖蛋白IIb / IIIa抑制剂在急性冠脉综合征血运重建过程中的疗效和安全性：对使用支架和噻吩并吡啶类药物进行的随机试验的荟萃分析
2. Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta‐Analysis of Randomized Trials Performed With Stents and Thienopyridines [J] . Anthony A. Bavry MD MPH, Ki E. Park MD, Xuerong Wen MPH, Clinical cardiology. . 2012,第2期

机译：普通肝素加糖蛋白IIb / IIIa抑制剂在急性冠脉综合征血运重建过程中的功效和安全性：支架和噻吩并吡啶类药物随机试验的荟萃分析
3. Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. [J] . Winchester DE, Wen X, Brearley WD, Journal of the American College of Cardiology . 2011,第10期

机译：糖蛋白IIb / IIIa抑制剂在选择性冠状动脉血运重建过程中的功效和安全性：对在支架和噻吩并吡啶时代进行的随机试验的荟萃分析。
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [O] . Haiyan Xu, Bingjian Wang, Jing Yang, -1

机译：比伐卢定vs肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的妇女中：一项荟萃分析的随机对照试验。
7. Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A Meta-Analysis of Randomized Trials Performed in the Era of Stents and Thienopyridines [O] . Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida ( host institution ), Winchester, David E. ( UF author ), Wen, Xuerong ( UF author ), 2011

机译：选择性冠状动脉血运重建过程中糖蛋白IIb / IIIa抑制剂的功效和安全性在支架和噻吩并吡啶时代进行的随机试验的荟萃分析

Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta‐Analysis of Randomized Trials Performed With Stents and Thienopyridines

摘要

著录项

相似文献

相关主题

期刊订阅